Skip to main content
Bing Xia, MD, Oncology, Los Angeles, CA

BingXiaMD

Oncology Los Angeles, CA

Head & Neck Cancer, Hematologic Oncology, Thoracic Cancer

Assistant Professor at USC Keck School of Medicine

Dr. Xia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Xia's full profile

Already have an account?

  • Office

    1441 Eastlake Ave
    Los Angeles, CA 90089
    Phone+1 323-865-3105

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 2011 - 2014
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 2011
  • University of Pennsylvania
    University of PennsylvaniaBA, Biology, Magna Cum Laude

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2017 - 2025
  • CT State Medical License
    CT State Medical License 2014 - 2020
  • RI State Medical License
    RI State Medical License 2017 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • HER2 Amplification in EGFR Mutant NSCLC After Acquired Resistance to EGFR-directed Therapies
    Bing Xia, Anna Wurtz, Scott N. Gettinger, Roy S. Herbst, Anne C. Chiang, Mimi Wan, Jeffrey Sklar, Veronique Neumeister, Katerina A. Politi and Sarah B. Goldberg, ASCO Annual Meeting, Chicago, IL, 6/4/2016
  • HER2 Amplification in EGFR Mutant NSCLC After Acquired Resistance to First and Second Generation EGFR-Inhibitors
    Bing Xia, Anna Wurtz, Scott N. Gettinger, Roy S. Herbst, Anne C. Chiang, Mimi Wan, Jeffrey Sklar, Veronique Neumeister, Katerina A. Politi and Sarah B. Goldberg, International Association for the Study of Lung Cancer (IASLC) 16th Annual Targeted Therapies of Lung Cancer Meeting, Santa Monica, CA., 2/17/2016
  • Effect of Primary Tumor Size in Patients with Metastatic Non-Small-Cell Lung Cancer (NSCLC)
    Bing Xia, Feng Gao, Ramaswamy Govindan, Damiel Morgensztern, ASCO Annual Meeting, Chicago, IL, 6/1/2013
  • Join now to see all

Press Mentions

  • OncLive® Hosts the Latest State of the Science Summit™ on Non-Small Cell Lung Cancer
    OncLive® Hosts the Latest State of the Science Summit™ on Non-Small Cell Lung CancerApril 29th, 2019

Research History

  • Oncology FellowResearch has focused on investigating biomarkers and novel treatment strategies in non-small cell lung cancer (NSCLC). Particular interest in evaluating mechanisms of resistance in EGFR mutant disease and therapies for brain metastasis.2014 - Present

Professional Memberships

Other Languages

  • Chinese (Mandarin)